Author

Thjon J. Tang

ENDOSCOPIC REASSESSMENT OF CT2N0M0 ESOPHAGEAL ADENOCARCINOMA LEADS TO DOWNSTAGING TO T1 TUMORS AND PREVENTS UNNECESSARY ADJUVANT TREATMENT: A MULTICENTER PROSPECTIVE COHORT STUDY
ENDOSCOPIC REASSESSMENT OF CT2N0M0 ESOPHAGEAL ADENOCARCINOMA LEADS TO DOWNSTAGING TO T1 TUMORS AND PREVENTS UNNECESSARY ADJUVANT TREATMENT: A MULTICENTER PROSPECTIVE COHORT STUDY

Thjon J. Tang  et al.

RANDOM BIOPSIES FROM THE GASTRO-ESOPHAGEAL JUNCTION AFTER COMPLETE ERADICATION OF BARRETT’S ESOPHAGUS: UTILE OR FUTILE?
RANDOM BIOPSIES FROM THE GASTRO-ESOPHAGEAL JUNCTION AFTER COMPLETE ERADICATION OF BARRETT’S ESOPHAGUS: UTILE OR FUTILE?

Thjon J. Tang  et al.

POOR HEALING AND POOR SQUAMOUS REGENERATION AFTER RADIOFREQUENCY ABLATION THERAPY FOR EARLY BARRETT'S NEOPLASIA: INCIDENCE, RISK FACTORS, AND OUTCOMES
POOR HEALING AND POOR SQUAMOUS REGENERATION AFTER RADIOFREQUENCY ABLATION THERAPY FOR EARLY BARRETT'S NEOPLASIA: INCIDENCE, RISK FACTORS, AND OUTCOMES

Thjon J. Tang  et al.

THE NATURAL COURSE OF UNTREATED NEOPLASIA IN BARRETT’S ESOPHAGUS - A CASE-SERIES
THE NATURAL COURSE OF UNTREATED NEOPLASIA IN BARRETT’S ESOPHAGUS - A CASE-SERIES

Thjon J. Tang  et al.

ENDOSCOPIC SUBMUCOSAL DISSECTION FOR BARRETT'S RELATED NEOPLASIA IN THE NETHERLANDS: RESULTS OF A NATIONWIDE COHORT OF 130 CASES
ENDOSCOPIC SUBMUCOSAL DISSECTION FOR BARRETT'S RELATED NEOPLASIA IN THE NETHERLANDS: RESULTS OF A NATIONWIDE COHORT OF 130 CASES

Thjon J. Tang  et al.

HIGH RISK FOR UNRELATED MORTALITY AFTER SUCCESSFUL ENDOSCOPIC ERADICATION THERAPY FOR BARRETT’S NEOPLASIA IN A NATIONWIDE COHORT OF 1154 PATIENTS
HIGH RISK FOR UNRELATED MORTALITY AFTER SUCCESSFUL ENDOSCOPIC ERADICATION THERAPY FOR BARRETT’S NEOPLASIA IN A NATIONWIDE COHORT OF 1154 PATIENTS

Thjon J. Tang  et al.

PREDICTION OF MORTALITY CAUSED BY OTHER CAUSES THAN ESOPHAGEAL ADENOCARCINOMA AFTER SUCCESSFUL ENDOSCOPIC ERADICATION THERAPY FOR BARRETT’S NEOPLASIA USING THE CHARLSON COMORBIDITY INDEX
PREDICTION OF MORTALITY CAUSED BY OTHER CAUSES THAN ESOPHAGEAL ADENOCARCINOMA AFTER SUCCESSFUL ENDOSCOPIC ERADICATION THERAPY FOR BARRETT’S NEOPLASIA USING THE CHARLSON COMORBIDITY INDEX

Thjon J. Tang  et al.

RISK OF RESIDUAL CANCER AFTER ENDOSCOPIC RESECTION OF EARLY BARRETT’S NEOPLASIA WITH CONFIRMED VERTICAL R1 MARGIN: A NATIONWIDE COHORT IN THE NETHERLANDS
RISK OF RESIDUAL CANCER AFTER ENDOSCOPIC RESECTION OF EARLY BARRETT’S NEOPLASIA WITH CONFIRMED VERTICAL R1 MARGIN: A NATIONWIDE COHORT IN THE NETHERLANDS

Thjon J. Tang  et al.

Item 1 - 8 / 8
1